The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Lisette Jensen
Showing 1-20 of 21 articles
Polymer-free biolimus-coated stents versus ultrathin-strut biodegradable polymer sirolimus-eluting stents: two-year outcomes of the randomised SORT OUT IX trial
Ellert-Gregersen J,
Jensen L,
Jakobsen L,
Freeman PM,
Eftekhari A,
Maeng M,
Raungaard B,
Engstroem T,
Kahlert J,
Hansen H,
Christiansen E
June 3, 2022 | 10.4244/EIJ-D-21-00874
Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial
Sabaté M,
Jensen L,
Tilsted H,
Moreno R,
García del Blanco B,
Macaya C,
Perez de Prado A,
Cequier A,
Pérez-Fuentes P,
Schütte D,
Costa R,
Stoll H,
Lassen JF
June 25, 2021 | 10.4244/EIJ-D-20-01162
Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study
Pareek M,
Madsen M,
Warnakula Olesen K,
Jensen L,
Christiansen E,
Kristensen SD,
Lassen JF,
Thuesen L,
Bøtker H,
Maeng M
December 6, 2019 | 10.4244/EIJ-D-19-00503
Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal model
Moller-Helgestad OK,
Hyldebrandt JA,
Banke A,
Rud CS,
Udesen NLJ,
Linde L,
Jensen L,
Schmidt H,
Ravn HB,
Moller JE
February 7, 2019 | 10.4244/EIJ-D-18-00684
Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)
Katagiri Y,
Onuma Y,
Asano T,
Iñiguez A,
Jensen L,
Cequier A,
Hofma S,
Christiansen E,
Suttorp M,
Brugaletta S,
Räber L,
Sabaté M,
Windecker S,
Serruys P
December 7, 2018 | 10.4244/EIJ-D-18-00839
One-year rehospitalisation after percutaneous coronary intervention: a retrospective analysis
Hansen KN,
Bendix K,
Antonsen L,
Veien K,
Maeng M,
Junker A,
Christiansen E,
Kahlert J,
Terkelsen CJ,
Christensen LB,
Fallesen C,
Bøtker H,
Jensen L
October 19, 2018 | 10.4244/EIJ-D-17-00800
Percutaneous biventricular cardiac assist device in cardiogenic shock and refractory cardiac arrest
Ellert J,
Jensen MJ,
Jensen L,
Moller JE
April 6, 2018 | 10.4244/EIJ-D-17-00637
How should I treat a bioresorbable vascular scaffold edge restenosis and intra-scaffold dissection?
Fallesen C,
Antonsen L,
Thayssen P,
Jensen L
February 20, 2018 | 10.4244/EIJ-D-17-00309
Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial)
Jensen L,
Maeng M,
Raungaard B,
Hansen K,
Kahlert J,
Jensen SE,
Hansen H,
Lassen JF,
Bøtker H,
Christiansen E
January 19, 2018 | 10.4244/EIJ-D-17-00731
Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents
Jakobsen L,
Christiansen E,
Maeng M,
Hansen K,
Kristensen SD,
Bøtker H,
Terkelsen CJ,
Jensen SE,
Raungaard B,
Madsen M,
Lassen JF,
Jensen L
December 20, 2017 | 10.4244/EIJ-D-17-00434
Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study
Räber L,
Onuma Y,
Brugaletta S,
Garcia-Garcia H,
Backx B,
Iñiguez A,
Jensen L,
Cequier-Fillat A,
Pilgrim T,
Christiansen E,
Hofma S,
Suttorp M,
Serruys P,
Sabaté M,
Windecker S
July 20, 2016 | 10.4244/EIJY15M08_03
Outcome with invasive versus medical treatment of stable coronary artery disease: influence of perfusion defect size, ischaemia, and ejection fraction
Simonsen J,
Johansen A,
Gerke O,
Mickley H,
Thomassen A,
Hess S,
Rask C,
Tamadoni M,
Jensen L,
Hallas J,
Vach W,
Hoilund-Carlsen P
February 19, 2016 | 10.4244/EIJV11I10A226
Very late stent thrombosis caused by neoatherosclerotic plaque rupture
Hougaard M,
Thayssen P,
Hansen H,
Jensen L
April 20, 2015 | 10.4244/EIJV10I12A251
Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial
Antonsen L,
Thayssen P,
Hansen H,
Maeng M,
Tilsted H,
Bøtker H,
Ravkilde J,
Madsen M,
Sørensen H,
Thuesen L,
Lassen JF,
Jensen L
June 20, 2014 | 10.4244/EIJV10I2A35
Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with ST-segment elevation acute myocardial infarction: the VIRHISTAMI trial
Egede R,
Jensen L,
Hansen H,
Hansen K,
Junker A,
Thayssen P
February 22, 2013 | 10.4244/EIJV8I10A182
Sex- and age-related differences in clinical outcome after primary percutaneous coronary intervention
Jakobsen L,
Niemann T,
Thorsgaard N,
Nielsen T,
Thuesen L,
Lassen JF,
Jensen L,
Thayssen P,
Ravkilde J,
Tilsted H,
Mehnert F,
Johnsen SP
December 28, 2012 | 10.4244/EIJV8I8A139
The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation
Thayssen P,
Jensen L,
Lassen JF,
Tilsted H,
Kaltoft A,
Christiansen E,
Hansen K,
Ravkilde J,
Maeng M,
Krusell L,
Madsen M,
Sørensen H,
Thuesen L
September 28, 2012 | 10.4244/EIJV8I5A91
Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease
Jensen L,
Thayssen P,
Farkas D,
Hougaard M,
Terkelsen CJ,
Tilsted H,
Maeng M,
Junker A,
Lassen JF,
Horv E,
Sørensen H,
Thuesen L
August 24, 2012 | 10.4244/EIJV8I4A72
Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial
Jensen L,
Maeng M,
Thayssen P,
Villadsen AB,
Krusell L,
Bøtker H,
Pedersen K,
Aaroe J,
Christiansen E,
Vesterlund T,
Hansen K,
Ravkilde J,
Tilsted H,
Lassen JF,
Thuesen L
July 29, 2011 | 10.4244/EIJV7I3A56
Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes
Jensen L,
Tilsted H,
Thayssen P,
Kaltoft A,
Maeng M,
Lassen JF,
Noerregaard Hansen K,
Madsen M,
Ravkilde J,
Johnsen S,
Sørensen H,
Thuesen L
April 12, 2010
1
2
Latest news
NEW ISSUE
The Bifurcation ARC consensus; impact of P2Y12 de-escalation in HBR; 5-year outcomes of the TARGET trial and more...
December 4, 2023
STATE-OF-THE-ART
Free access collection all year long
December 4, 2023
AHEAD OF PRINT
Poor improvement of post-PCI iFR in LAD
FREE ARTICLE - Mitsuaki Matsumura et al
November 30, 2023
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
PCR London Valves 2023
November 16, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023